Subsequent Events

12 Months Ended

Jun. 30, 2014

Subsequent Events

Subsequent Events

Note 21.  Subsequent Events

Patent Infringement (Paragraph IV Certification)

In July 2014, in response to a paragraph IV certification with respect to the Zomig® nasal spray product, AstraZeneca AB, AstraZeneca UK Limited and Impax Laboratories, Inc. filed two patent infringement complaints against the Company.  Refer to Note 11 “Legal and Regulatory Matters” for additional information.

Connecticut Attorney General Inquiry

In July 2014, the Company received interrogatories and subpoena from the State of Connecticut Office of the Attorney General concerning its investigation into pricing of digoxin.  Refer to Note 11 “Legal and Regulatory Matters” for additional information.

Class Action-David Schaefer

On August 27, 2014, David Schaefer, as an alleged class representative, filed a class action complaint against the Company and certain of its officers.  Refer to Note 11 “Legal and Regulatory Matters” for additional information.